The Plastic Surgeon's Verdict: Gender Surgery Is Mutilation, Not Medicine - Dr.Patrick Lappert (#30)
18 August 2025
With Patrick Lappert
Global
Dr Patrick Lappert, a board-certified plastic and reconstructive surgeon with four decades of clinical experience, argues that gender surgeries rest on Level 5 evidence — expert opinion alone, the lowest tier in the research hierarchy. He contends that the procedures violate his specialty's own ethical codes on body dysmorphic disorder, and draws on European outcome data to question how a claim to evidence-based practice has been sustained without the evidence that phrase ordinarily requires.
Dr Patrick Lappert trained in general surgery before the United States Navy sent him for specialist plastic and reconstructive surgical training. That career, spanning more than forty years in both military and civilian practice, gave him an unusually precise vantage point on the procedures now described as gender-affirming care. He has since testified at state and federal level on gender surgeries, and in this episode he applies the clinical and ethical standards of his own specialty to assess whether those procedures meet the bar his field demands. The most consequential argument Lappert advances concerns the quality of evidence underpinning the entire field. He describes gender surgeries as operating on Level 5 evidence — the weakest category in the research hierarchy, consisting of expert opinion rather than randomised controlled trials, cohort studies or systematic reviews. The designation matters because standard-of-care language has been used to legitimise these procedures in clinical guidelines and legal proceedings on both sides of the Atlantic, including in European countries that cited that framing when establishing policy. The absence of higher-quality evidence was also central to the health technology assessments that led Sweden, Finland, England and Denmark to restrict or pause youth gender medicine between 2020 and 2024. Lappert describes the specific outcomes of the principal procedures in clinical terms. He characterises phalloplasty as producing a result that is essentially non-functional, and sets out the anatomical reasons why vaginoplasty carries a documented risk of fistula formation between the surgically constructed cavity and the bowel. He also addresses chest masculinisation in female patients, arguing that the procedure permanently severs a nerve pathway integral to the physiological process involved in breastfeeding — a consequence he frames not as a cosmetic trade-off but as irreversible damage to a biological function. A further line of argument concerns the relationship between gender dysphoria and body dysmorphic disorder. Lappert contends that plastic surgery's own ethical codes explicitly prohibit surgeons from operating on patients whose primary presentation is a distorted perception of their own body, and that gender surgeries, by his clinical assessment, fall within that prohibition. He draws a parallel with obsessive-compulsive disorder, a comparison that reflects a strand of psychiatric literature that has informed caution among clinicians and health technology reviewers in several European jurisdictions. The episode references Swedish longitudinal data showing substantially elevated mortality and self-harm rates in the years following surgical transition. That finding is consistent with the long-term follow-up studies that proved pivotal in prompting Nordic policy reversals and that featured prominently in the Cass Review's appraisal of the evidence base in England. Lappert argues that this data, taken together with the absence of prospective controlled evidence, makes the ongoing performance of these procedures difficult to sustain under standard frameworks of medical ethics and informed consent. For those following the European policy debate, Lappert's testimony adds a practitioner's inside account of how a surgical specialty came to offer procedures that its own professional codes arguably forbid, and how standard-of-care claims came to be advanced in the absence of the evidentiary foundation that phrase normally requires. His account complements the epidemiological and systematic-review literature that has driven legislative and regulatory scrutiny across a growing number of European countries.
